禮來與諾和諾德差距在最新財報後進一步擴大

2026-08-06 · cnbc.com

隨著禮來在肥胖症領域擴大領先優勢，諾和諾德仍努力追趕以奪回市佔率，並恢復投資人對其產品研發線的信心。

"While Novo raised guidance (as expected), the pipeline and path to sustainable growth remain less clear," BMO Capital Markets analyst Evan Seigerman said in a ...